Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Physiological Reports
|
December 15, 2018
Apelinergic system in the kidney: implications for diabetic kidney disease
Tilman Müller, Anastasia Z Kalea, Alonso Marquez, et al.
American Journal of Hypertension
|
March 6, 2013
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats
Jasmina Varagic, Sarfaraz Ahmad, Jessica L VonCannon, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infection
Luise Hassler, Jan Wysocki, Ian Gelarden, et al.
Cell Stress & Chaperones
|
June 25, 2003
Characterization of the anti-DnaJ monoclonal antibodies and their use to compare immunological properties of DnaJ and its human homologue HDJ-1
Konrad Krzewski, Danuta Kunikowska, Jan Wysocki, et al.
Kidney International
|
December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy
Jan Wysocki, Minghao Ye, Ahmed M Khattab, et al.
Journal of the American Society of Nephrology : JASN
|
February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids
Jan Wysocki, Minghao Ye, Luise Hassler, et al.
Kidney International
|
April 6, 2012
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
Renisha Nadarajah, Rosangela Milagres, Marc Dilauro, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2
Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
Kidney International Reports
|
December 12, 2022
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy
Jessica Navarro, Alejandro Sanchez, Sheeba H Ba Aqeel, et al.
Kidney International
|
April 26, 2018
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
Pan Liu, Jan Wysocki, Tomokazu Souma, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Physiological Reports
|
December 15, 2018
Apelinergic system in the kidney: implications for diabetic kidney disease
Tilman Müller, Anastasia Z Kalea, Alonso Marquez, et al.
American Journal of Hypertension
|
March 6, 2013
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats
Jasmina Varagic, Sarfaraz Ahmad, Jessica L VonCannon, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infection
Luise Hassler, Jan Wysocki, Ian Gelarden, et al.
Cell Stress & Chaperones
|
June 25, 2003
Characterization of the anti-DnaJ monoclonal antibodies and their use to compare immunological properties of DnaJ and its human homologue HDJ-1
Konrad Krzewski, Danuta Kunikowska, Jan Wysocki, et al.
Kidney International
|
December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy
Jan Wysocki, Minghao Ye, Ahmed M Khattab, et al.
Journal of the American Society of Nephrology : JASN
|
February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids
Jan Wysocki, Minghao Ye, Luise Hassler, et al.
Kidney International
|
April 6, 2012
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
Renisha Nadarajah, Rosangela Milagres, Marc Dilauro, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2
Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
Kidney International Reports
|
December 12, 2022
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy
Jessica Navarro, Alejandro Sanchez, Sheeba H Ba Aqeel, et al.
Kidney International
|
April 26, 2018
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
Pan Liu, Jan Wysocki, Tomokazu Souma, et al.
Page
of 8